No association of chronic cerebrospinal venous insufficiency with multiple sclerosis
RJ Fox, C Diaconu, L Baus, A Grattan… - Canadian Journal of …, 2016 - cambridge.org
… association with multiple sclerosis. CMAJ. 2014;186:E418-26. … study of the prevalence of
chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. …
chronic cerebrospinal venous insufficiency in multiple sclerosis: results from the CoSMo study. …
Four-dimensional flow magnetic resonance imaging and ultrasound assessment of cerebrospinal venous flow in multiple sclerosis patients and controls
EM Schrauben, S Kohn, J Macdonald… - Journal of Cerebral …, 2017 - journals.sagepub.com
… multiple diagnostic imaging modalities across a large patient and control population. In this
study… venous insufficiency hypothesis in patients with multiple sclerosis and two age- and sex-…
study… venous insufficiency hypothesis in patients with multiple sclerosis and two age- and sex-…
Magnetic resonance imaging of internal jugular veins in multiple sclerosis: Interobserver agreement and comparison with Doppler ultrasound examination
SJ Laukontaus, J Pekkola, J Numminen… - Annals of Vascular …, 2017 - Elsevier
… evaluate the cervical venous system of multiple sclerosis patients according to the hypothesis
… and MRI in the detection of calibers of ≤0.3 cm 2 in the IJV CSA in the prospective study. …
… and MRI in the detection of calibers of ≤0.3 cm 2 in the IJV CSA in the prospective study. …
Fuzziness of muscle synergies in patients with multiple sclerosis indicates increased robustness of motor control during walking
… Deficits during gait poses a significant threat to the quality of life in patients with Multiple
Sclerosis (MS). Using the muscle synergy concept, we investigated the modular organization of …
Sclerosis (MS). Using the muscle synergy concept, we investigated the modular organization of …
Ocrelizumab treatment modulates B-cell regulating factors in multiple sclerosis
S Ho, E Oswald, HK Wong, A Vural… - Neurology …, 2023 - AAN Enterprises
… Antibodies to CD20 efficiently reduce new relapses in multiple sclerosis (MS), and
ocrelizumab has been shown to be effective also in primary progressive MS. Although anti-CD20 …
ocrelizumab has been shown to be effective also in primary progressive MS. Although anti-CD20 …
[HTML][HTML] Signatures of cell stress and altered bioenergetics in skin fibroblasts from patients with multiple sclerosis
JM Wilkins, O Gakh, P Kabiraj, CB McCarthy… - Aging (Albany …, 2020 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a central nervous system inflammatory demyelinating disease and
the most common cause of non-traumatic disability in young adults. Despite progress in the …
the most common cause of non-traumatic disability in young adults. Despite progress in the …
Effect of Cosmos Caudatus Leaf Ethanol Extract on Serum Inos Level in Rats with Liver Disorder
EJ Anto, LD Prasetiani - The International Conference on Public …, 2023 - theicph.com
… , arthritis, multiple sclerosis, … Cosmos caudatus) is a natural and traditional medicine
believed to have a hepatoprotective effect. This study aimed to determine the efficacy of Cosmos …
believed to have a hepatoprotective effect. This study aimed to determine the efficacy of Cosmos …
Cognitive implications of deep gray matter iron in multiple sclerosis
E Fujiwara, JA Kmech, D Cobzas… - American Journal …, 2017 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Deep gray matter iron accumulation is increasingly
recognized in association with multiple sclerosis and can be measured in vivo with MR imaging. …
recognized in association with multiple sclerosis and can be measured in vivo with MR imaging. …
Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in clinically isolated syndrome
AM Al-Radaideh, SJ Wharton, SY Lim… - Multiple Sclerosis …, 2013 - journals.sagepub.com
… with multiple sclerosis (MS), from both in vivo magnetic resonance imaging (MRI) and …
studies, 1 but it is not clear how early in the disease these changes occur. Our study addresses …
studies, 1 but it is not clear how early in the disease these changes occur. Our study addresses …
Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort
J Murphy, P Factor-Litvak, R Goetz, C Lomen-Hoerth… - Neurology, 2016 - AAN Enterprises
… useful in patient populations with multiple sclerosis and Parkinson disease, who are …
COSMOS study are reported elsewhere. Among 355 patients enrolled in the ALS COSMOS study, …
COSMOS study are reported elsewhere. Among 355 patients enrolled in the ALS COSMOS study, …